Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)- Insider Own0.59% Shs Outstand8.83M Perf Week75.14%
Market Cap5.69M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float8.78M Perf Month321.52%
Income- PEG- EPS next Q- Inst Own10.07% Short Float / Ratio5.86% / 0.06 Perf Quarter88.89%
Sales- P/S- EPS this Y- Inst Trans4.18% Short Interest0.51M Perf Half Y-22.35%
Book/sh-0.26 P/B- EPS next Y- ROA- Target Price287.34 Perf Year-89.17%
Cash/sh0.01 P/C94.85 EPS next 5Y- ROE- 52W Range0.09 - 6.16 Perf YTD-86.71%
Dividend- P/FCF- EPS past 5Y57.79% ROI- 52W High-89.54% Beta1.98
Dividend %- Quick Ratio0.27 Sales past 5Y71.59% Gross Margin- 52W Low585.64% ATR0.09
Employees18 Current Ratio0.32 Sales Q/Q- Oper. Margin-1363.43% RSI (14)78.62 Volatility69.26% 40.37%
OptionableNo Debt/Eq- EPS Q/Q87.98% Profit Margin- Rel Volume13.89 Prev Close0.23
ShortableNo LT Debt/Eq- EarningsSep 12 BMO Payout- Avg Volume9.19M Price0.64
Recom1.00 SMA20256.82% SMA50222.49% SMA200-16.59% Volume127,579,122 Change180.22%
Nov-29-23 10:20AM
Nov-27-23 08:48AM
Nov-17-23 02:45PM
Nov-10-23 08:47AM
08:47AM Loading…
Sep-14-23 08:47AM
Sep-12-23 07:30AM
Sep-06-23 08:47AM
Aug-23-23 08:47AM
Jul-20-23 08:47AM
Jul-17-23 08:47AM
Jul-06-23 08:00AM
Jul-05-23 08:47AM
Jun-15-23 08:47AM
May-31-23 04:30PM
08:47AM Loading…
May-24-23 08:47AM
May-16-23 07:30AM
May-12-23 08:47AM
May-09-23 07:15AM
May-01-23 08:47AM
Apr-12-23 09:30AM
Apr-11-23 09:58AM
Apr-10-23 08:47AM
Mar-22-23 08:47AM
Mar-15-23 08:47AM
Mar-03-23 08:47AM
Feb-27-23 08:47AM
Feb-14-23 08:47AM
Feb-07-23 08:47AM
Jan-27-23 08:47AM
08:17AM Loading…
Jan-24-23 08:17AM
Jan-10-23 08:47AM
Dec-19-22 08:47AM
Dec-02-22 08:47AM
Nov-30-22 08:47AM
Nov-22-22 08:47AM
Nov-10-22 08:47AM
Nov-09-22 08:47AM
Nov-08-22 08:47AM
Oct-24-22 08:47AM
Oct-21-22 08:47AM
Oct-13-22 08:47AM
Oct-03-22 08:47AM
Sep-27-22 08:47AM
Sep-13-22 08:47AM
Sep-08-22 08:57AM
Aug-30-22 09:24AM
Aug-03-22 12:15PM
Aug-01-22 08:47AM
Jul-28-22 08:47AM
Jul-25-22 08:47AM
Jul-19-22 08:47AM
Jul-12-22 08:47AM
Jun-29-22 07:30AM
Jun-27-22 08:30AM
Jun-23-22 08:47AM
Jun-13-22 08:47AM
Jun-09-22 05:25PM
Jun-08-22 08:47AM
May-31-22 08:47AM
May-23-22 08:47AM
May-20-22 09:00AM
May-19-22 09:00AM
May-18-22 08:47AM
May-05-22 08:47AM
Apr-19-22 09:00AM
Apr-12-22 07:30AM
Apr-11-22 08:47AM
Apr-04-22 08:47AM
Mar-15-22 09:00AM
Mar-11-22 09:00AM
Mar-09-22 09:00AM
Mar-04-22 09:15AM
Feb-14-22 09:00AM
Feb-09-22 09:00AM
Feb-07-22 09:00AM
Feb-04-22 09:25AM
Jan-21-22 09:00AM
Jan-13-22 09:00AM
Jan-05-22 09:00AM
Dec-29-21 09:15AM
Dec-16-21 09:00AM
Dec-01-21 09:00AM
Nov-15-21 09:00AM
Nov-12-21 09:00AM
Oct-25-21 09:00AM
Oct-14-21 08:00AM
Oct-06-21 08:00AM
Oct-01-21 08:04PM
Sep-27-21 07:45AM
Sep-21-21 08:00AM
Sep-09-21 08:30AM
Sep-08-21 08:30AM
Aug-06-21 09:00AM
Aug-03-21 09:00AM
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.